vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and EASTERN CO (EML). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $55.3M, roughly 1.5× EASTERN CO). BillionToOne, Inc. runs the higher net margin — 6.8% vs 1.0%, a 5.8% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -22.4%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $3.1M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
BLLN vs EML — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $55.3M |
| Net Profit | $5.7M | $578.9K |
| Gross Margin | 69.9% | 22.3% |
| Operating Margin | 11.5% | 3.1% |
| Net Margin | 6.8% | 1.0% |
| Revenue YoY | 117.4% | -22.4% |
| Net Profit YoY | 138.3% | 103.8% |
| EPS (diluted) | $0.10 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | $55.3M | ||
| Q2 25 | — | $70.2M | ||
| Q1 25 | — | $63.3M | ||
| Q4 24 | — | $64.3M | ||
| Q3 24 | $38.4M | $71.3M | ||
| Q2 24 | — | $72.6M | ||
| Q1 24 | — | $64.6M | ||
| Q4 23 | — | $56.0M |
| Q3 25 | $5.7M | $578.9K | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | $-14.9M | $-15.3M | ||
| Q2 24 | — | $3.5M | ||
| Q1 24 | — | $1.9M | ||
| Q4 23 | — | $3.5M |
| Q3 25 | 69.9% | 22.3% | ||
| Q2 25 | — | 23.3% | ||
| Q1 25 | — | 22.4% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | 52.6% | 25.5% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 23.9% | ||
| Q4 23 | — | 28.0% |
| Q3 25 | 11.5% | 3.1% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -32.9% | 9.5% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 5.3% | ||
| Q4 23 | — | 12.3% |
| Q3 25 | 6.8% | 1.0% | ||
| Q2 25 | — | 4.9% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | -38.8% | -21.5% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 3.0% | ||
| Q4 23 | — | 6.3% |
| Q3 25 | $0.10 | $0.10 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $0.32 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-1.47 | $-2.46 | ||
| Q2 24 | — | $0.56 | ||
| Q1 24 | — | $0.31 | ||
| Q4 23 | — | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $9.2M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $124.3M |
| Total Assets | $327.5M | $220.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $195.2M | $9.2M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $9.7M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $2.1M | ||
| Q4 23 | — | $9.0M |
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $42.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $43.9M |
| Q3 25 | $-239.5M | $124.3M | ||
| Q2 25 | — | $124.4M | ||
| Q1 25 | — | $121.0M | ||
| Q4 24 | — | $120.7M | ||
| Q3 24 | $-242.9M | $119.2M | ||
| Q2 24 | — | $136.5M | ||
| Q1 24 | — | $134.5M | ||
| Q4 23 | — | $132.5M |
| Q3 25 | $327.5M | $220.0M | ||
| Q2 25 | — | $229.4M | ||
| Q1 25 | — | $232.3M | ||
| Q4 24 | — | $235.3M | ||
| Q3 24 | — | $244.2M | ||
| Q2 24 | — | $255.9M | ||
| Q1 24 | — | $253.9M | ||
| Q4 23 | — | $252.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.35× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 0.33× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $3.1M |
| Free Cash FlowOCF − Capex | $6.5M | $3.1M |
| FCF MarginFCF / Revenue | 7.7% | 5.5% |
| Capex IntensityCapex / Revenue | 8.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.42× | 5.38× |
| TTM Free Cash FlowTrailing 4 quarters | — | $12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $13.8M | $3.1M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $-1.8M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | — | $-2.9M | ||
| Q2 24 | — | $8.4M | ||
| Q1 24 | — | $2.8M | ||
| Q4 23 | — | $7.4M |
| Q3 25 | $6.5M | $3.1M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $1.1M | ||
| Q4 23 | — | $5.9M |
| Q3 25 | 7.7% | 5.5% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | -4.3% | ||
| Q4 24 | — | 13.9% | ||
| Q3 24 | — | -10.8% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 10.6% |
| Q3 25 | 8.8% | 0.1% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 2.6% | ||
| Q4 23 | — | 2.6% |
| Q3 25 | 2.42× | 5.38× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | -0.95× | ||
| Q4 24 | — | 8.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.40× | ||
| Q1 24 | — | 1.43× | ||
| Q4 23 | — | 2.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
EML
Segment breakdown not available.
